GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » PB Ratio

Theralase Technologies (TSXV:TLT) PB Ratio : 18.75 (As of May. 30, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-30), Theralase Technologies's share price is C$0.15. Theralase Technologies's Book Value per Share for the quarter that ended in Dec. 2023 was C$0.01. Hence, Theralase Technologies's PB Ratio of today is 18.75.

The historical rank and industry rank for Theralase Technologies's PB Ratio or its related term are showing as below:

TSXV:TLT' s PB Ratio Range Over the Past 10 Years
Min: 2.39   Med: 12.5   Max: 87.5
Current: 20

During the past 13 years, Theralase Technologies's highest PB Ratio was 87.50. The lowest was 2.39. And the median was 12.50.

TSXV:TLT's PB Ratio is ranked worse than
97.46% of 788 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs TSXV:TLT: 20.00

During the past 12 months, Theralase Technologies's average Book Value Per Share Growth Rate was -42.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -43.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -12.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -9.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Theralase Technologies was 194.30% per year. The lowest was -50.90% per year. And the median was 14.60% per year.

Back to Basics: PB Ratio


Theralase Technologies PB Ratio Historical Data

The historical data trend for Theralase Technologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies PB Ratio Chart

Theralase Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.07 4.22 15.00 22.86 21.88

Theralase Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.88 22.86 30.00 32.86 21.88

Competitive Comparison of Theralase Technologies's PB Ratio

For the Medical Devices subindustry, Theralase Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theralase Technologies's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's PB Ratio falls into.



Theralase Technologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Theralase Technologies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.15/0.008
=18.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Theralase Technologies  (TSXV:TLT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Theralase Technologies PB Ratio Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Theralase Technologies (TSXV:TLT) Business Description

Traded in Other Exchanges
Address
41 Hollinger Road, Toronto, ON, CAN, M4B 3G4
Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.
Executives
Matthew Thomas Perraton Director

Theralase Technologies (TSXV:TLT) Headlines

From GuruFocus

Top 5 3rd Quarter Trades of Eqis Capital Management, Inc.

By GuruFocus Research GuruFocus Editor 10-24-2022

Top 5 3rd Quarter Trades of CADINHA & CO LLC

By GuruFocus Research GuruFocus Editor 10-22-2022

Matrix Trust Co Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-03-2022

Financial Sense Advisors, Inc. Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-18-2022

Top 5 4th Quarter Trades of Mechanics Bank Trust Department

By GuruFocus Research GuruFocus Editor 01-24-2023

Top 5 4th Quarter Trades of Starfox Financial Services, LLC

By GuruFocus Research GuruFocus Editor 02-08-2023

Top 5 4th Quarter Trades of Rothschild Capital Partners, LLC

By GuruFocus Research GuruFocus Editor 02-15-2023

Top 5 3rd Quarter Trades of Checchi Capital Advisers, LLC

By GuruFocus Research GuruFocus Editor 11-10-2022

Top 5 2nd Quarter Trades of Louis Moore Bacon

By GuruFocus Research GuruFocus Editor 08-15-2022

Rafferty Asset Management, LLC's Top 5 Buys of the 4th Quarter

By GuruFocus Research GuruFocus Editor 02-15-2023